|1||NCT00064116||Completed||Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma||
||824||All||18 Years to 60 Years (Adult)||NCT00064116||LY9
|May 2001||December 2010||January 2014||July 9, 2003||June 24, 2014||
|2||NCT03136497||Recruiting||A Study of ABT-199 Plus Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma||
||Other / Industry||
||30||All||18 Years and older (Adult, Senior)||NCT03136497||Pro00005671
|September 5, 2017||May 30, 2020||May 30, 2020||May 2, 2017||September 8, 2017||
† Study has passed its completion date and status has not been verified in more than two years.